Bulletin
Investor Alert

London Markets Close in:

Company Close Updates Archives | Email alerts

April 20, 2021, 4:31 p.m. EDT

Moderna Inc. stock falls Tuesday, underperforms market

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Moderna Inc. MRNA shed 3.17% to $156.78 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.92% to 13,786.27 and Dow Jones Industrial Average DJIA falling 0.75% to 33,821.30. This was the stock's second consecutive day of losses. Moderna Inc. closed $32.48 short of its 52-week high ($189.26), which the company reached on February 8th.

The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. ABBV rose 0.39% to $109.03, Amgen Inc. AMGN rose 1.24% to $259.14, and AstraZeneca PLC ADR AZN rose 1.24% to $52.27. Trading volume (7.1 M) remained 1.9 million below its 50-day average volume of 9.0 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Moderna Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.